评估阿片类镇痛药风险评估与缓解策略项目。 - Suppr

Suppr

超能文献

Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program.

作者信息

Auth Doris, Staffa Judy, LaCivita Cynthia

机构信息

Division of Risk Management, US Food and Drug Administration, Silver Spring, Maryland.

Office of Medication Error Prevention and Risk Management, US Food and Drug Administration, Silver Spring, Maryland.

出版信息

JAMA Intern Med. 2020 Jun 1;180(6):915-916. doi: 10.1001/jamainternmed.2020.1260.

DOI:10.1001/jamainternmed.2020.1260

PMID:32364564

Abstract

摘要

相似文献

Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program.

JAMA Intern Med. 2020 Jun 1;180(6):915-916. doi: 10.1001/jamainternmed.2020.1260.

Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program-Reply.

JAMA Intern Med. 2020 Jun 1;180(6):916. doi: 10.1001/jamainternmed.2020.1112.

Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).

JAMA. 2012 Aug 1;308(5):457-8. doi: 10.1001/jama.2012.8165.

Getting Serious About Opioid Regulation.

JAMA Intern Med. 2020 Feb 1;180(2):309-310. doi: 10.1001/jamainternmed.2019.5443.

The Food and Drug Administration Should Mandate Risk Evaluation and Mitigation Strategies Training for All Opioids.

Anesth Analg. 2018 Apr;126(4):1413-1417. doi: 10.1213/ANE.0000000000002888.

Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.

J Opioid Manag. 2017 May/Jun;13(3):157-168. doi: 10.5055/jom.2017.0383.

SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program.

Pain Med. 2016 Jan;17(1):52-63. doi: 10.1111/pme.12878.

Scientists, officials eye tools aimed at combating abuse of painkillers.

JAMA. 2012 Jan 4;307(1):19-21. doi: 10.1001/jama.2011.1900.

The Food and Drug Administration opioid Risk Evaluation and Mitigation Strategy.

J Pain Palliat Care Pharmacother. 2009;23(3):219-21. doi: 10.1080/15360280903098325.

Changes in Mortality Involving Extended-Release and Long-Acting Opioids After Implementation of a Risk Evaluation and Mitigation Strategy.

Pain Med. 2020 Jan 1;21(1):92-100. doi: 10.1093/pm/pnz031.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program.

作者信息

Auth Doris, Staffa Judy, LaCivita Cynthia

机构信息

Division of Risk Management, US Food and Drug Administration, Silver Spring, Maryland.

Office of Medication Error Prevention and Risk Management, US Food and Drug Administration, Silver Spring, Maryland.

出版信息

JAMA Intern Med. 2020 Jun 1;180(6):915-916. doi: 10.1001/jamainternmed.2020.1260.

DOI:10.1001/jamainternmed.2020.1260

PMID:32364564

Abstract

摘要

相似文献

Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program.

JAMA Intern Med. 2020 Jun 1;180(6):915-916. doi: 10.1001/jamainternmed.2020.1260.

Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program-Reply.

JAMA Intern Med. 2020 Jun 1;180(6):916. doi: 10.1001/jamainternmed.2020.1112.

Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).

JAMA. 2012 Aug 1;308(5):457-8. doi: 10.1001/jama.2012.8165.

Getting Serious About Opioid Regulation.

JAMA Intern Med. 2020 Feb 1;180(2):309-310. doi: 10.1001/jamainternmed.2019.5443.

The Food and Drug Administration Should Mandate Risk Evaluation and Mitigation Strategies Training for All Opioids.

Anesth Analg. 2018 Apr;126(4):1413-1417. doi: 10.1213/ANE.0000000000002888.

Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.

J Opioid Manag. 2017 May/Jun;13(3):157-168. doi: 10.5055/jom.2017.0383.

SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program.

Pain Med. 2016 Jan;17(1):52-63. doi: 10.1111/pme.12878.

Scientists, officials eye tools aimed at combating abuse of painkillers.

JAMA. 2012 Jan 4;307(1):19-21. doi: 10.1001/jama.2011.1900.

The Food and Drug Administration opioid Risk Evaluation and Mitigation Strategy.

J Pain Palliat Care Pharmacother. 2009;23(3):219-21. doi: 10.1080/15360280903098325.

Changes in Mortality Involving Extended-Release and Long-Acting Opioids After Implementation of a Risk Evaluation and Mitigation Strategy.

Pain Med. 2020 Jan 1;21(1):92-100. doi: 10.1093/pm/pnz031.